The FDA approved Scinopharm's glatiramer acetate injection, a generic version of Copaxone, to treat multiple sclerosis.

Mothers with MS face longer diagnostic delays than women without children, especially those who are employed or single.

NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

For the first time, UCL researchers have used AI to identify two biologically distinct forms of multiple sclerosis ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

NICE recommends natalizumab as a new treatment for adults with highly active relapsing-remitting multiple sclerosis ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Christina Applegate got emotional as she detailed her frustrations and fears over a recent multiple sclerosis (MS) flare-up.

Last month, the FDA declined to approve Sanofi’s tolebrutinib for a specific form of multiple sclerosis. In a recently ...

The 54-year-old star recalled a phase when she had experienced MS flare-up, a moment she described that felt like her own ...

Introduction: Multiple sclerosis (MS) and rheumatoid arthritis (RA) are common, chronic immune-mediated diseases that share pathogenetic pathways, but their epidemiological relationship is uncertain.